Stocks
CVS Health Reported Another Stellar Quarter Despite Busy Acquisitions, but Disappointed by Guidance
StocksCVS Health (CVS) stock is retreating more than 1.5% in premarket trading, being mostly affected by uncertainties over Fed’s rate decision tonight, rather than its freshly published quarterly results showing total revenues of $85.28 billion posted an 11% annual increase over the $76.83 billion.
May 3, 2023
1303
Popular posts
Cryptocurrencies
Ethereum “London” Change of Protocol: Big Deal or Much Ado About Nothing?
August 6, 2021
2550
Cryptocurrencies
Why Robinhood IPO is Highly Contingent on Crypto Market Performance
July 2, 2021
2472
Stocks
show more
Alibaba’s Earnings vs. China’s Regulatory Actions: Waiting for Stock Reentry Signals
August 4, 2021
2465